Azienda Ospedaliero Universitaria Federico II di Napoli

Naples 80131

1 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Crohn's Disease, Heterozygous Familial Hypercholesterolemia, Hypercholesterolemia, Primary Biliary Cholangitis (PBC)

Studies at this site

• A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis — Recruiting now
• A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease — Recruiting now
• Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer — Completed
• Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia — Completed
• A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia — Completed